Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo.
about
Immune tolerance after delivery of dying cells to dendritic cells in situIn vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigensDendritic cell mediated delivery of plasmid DNA encoding LAMP/HIV-1 Gag fusion immunogen enhances T cell epitope responses in HLA DR4 transgenic miceSteady state dendritic cells present parenchymal self-antigen and contribute to, but are not essential for, tolerization of naive and Th1 effector CD4 cells.Dendritic cells program non-immunogenic prostate-specific T cell responses beginning at early stages of prostate tumorigenesis.EGFRvIII-targeted immunotoxin induces antitumor immunity that is inhibited in the absence of CD4+ and CD8+ T cellsPeripheral Tolerization of Effector and Memory T Cells: Implications for Autoimmunity and Tumor-Immunity.Non-hematopoietic cells in lymph nodes drive memory CD8 T cell inflation during murine cytomegalovirus infection.Immunological tolerance to muscle autoantigens involves peripheral deletion of autoreactive CD8+ T cellsThe early expression of glycoprotein B from herpes simplex virus can be detected by antigen-specific CD8+ T cells.The enemy within: keeping self-reactive T cells at bay in the periphery.Skin-derived dendritic cells induce potent CD8(+) T cell immunity in recombinant lentivector-mediated genetic immunization.The role of dendritic cell subsets in selection between tolerance and immunity.Lipids, apoptosis, and cross-presentation: links in the chain of host defense against Mycobacterium tuberculosis.CD8+ regulatory T cells generated by neonatal recognition of peripheral self-antigenBeta cell MHC class I is a late requirement for diabetesMurine dendritic cell development: difficulties associated with subset analysis.Some interfaces of dendritic cell biology.CD169+ macrophages are sufficient for priming of CTLs with specificities left out by cross-priming dendritic cells.Beta cells cannot directly prime diabetogenic CD8 T cells in nonobese diabetic mice.Antibody-enhanced cross-presentation of self antigen breaks T cell tolerance.Cross-presentation: dendritic cells and macrophages bite off more than they can chew!Generation of tumor-associated cytotoxic T lymphocytes requires interleukin 4 from CD8(+) T cells.Uncoupling of proliferative potential and gain of effector function by CD8(+) T cells responding to self-antigens.Peripheral deletion of autoreactive CD8 T cells by cross presentation of self-antigen occurs by a Bcl-2-inhibitable pathway mediated by BimAntigen presentation by dendritic cells in vivo.The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens.Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node.Phenotypic and functional analysis of CD8(+) T cells undergoing peripheral deletion in response to cross-presentation of self-antigen.Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance.Role of T cells and dendritic cells in glomerular immunopathology.Too dangerous to ignore: self-tolerance and the control of ignorant autoreactive T cells.Targeted antigen delivery to DEC-205⁺ dendritic cells for tolerogenic vaccinationEnhancing the safety of antibody-based immunomodulatory cancer therapy without compromising therapeutic benefit: Can we have our cake and eat it too?Tissue destruction caused by cytotoxic T lymphocytes induces deletional tolerance.Demystifying the development of dendritic cell subtypes, a little.Rabbit polyclonal mouse antithymocyte globulin administration alters dendritic cell profile and function in NOD mice to suppress diabetogenic responses.The CD8+ dendritic cell subset.Defining dendritic cells by conditional and constitutive cell ablation.Induction/engineering, detection, selection, and expansion of clinical-grade human antigen-specific CD8 cytotoxic T cell clones for adoptive immunotherapy.
P2860
Q24673068-A167B8BF-F8CB-4275-B7FE-A47AD294C703Q29615098-36D1FC48-9E18-44D7-9EC5-7945BB582C73Q33522216-D8B1E31A-1C6D-4BFB-9FE7-F9106073033DQ33756646-7F2F4F99-19F6-4372-8331-E19C6F672631Q33756652-F81A6058-8F7D-46DD-A07D-2364A83CD66AQ33758468-2B967E14-BF94-425F-8D98-7B01B7D2A420Q33801059-30F5337F-58BE-447B-99DF-307B4ECB4524Q34064200-179DDD8A-064B-48F2-BE66-E08048C5732BQ34263314-E89BA2DB-9D25-4103-ABB3-6EFF8D0094D0Q34472265-01D21453-CB4A-4008-A24D-B78486D99A8EQ34573771-E2A43AF9-D256-4C40-B9DF-B76EEC3A0E94Q34801021-9410380C-3694-42C0-9918-8CC81AB46EC0Q34842295-0A355993-9314-424C-B46F-1D6DC8F51048Q35089558-E69A5EF4-2858-4102-A018-28C38C7A6D24Q35108103-76881D3C-1983-4477-847C-8024938E8949Q35143964-05E41F1C-F31D-4574-AA52-DF53DE474372Q35171877-12920F45-D519-4925-88B5-88DBBC9BEBC6Q35219290-8958B40A-17F9-4E4E-B9A2-D6D3C87EC4ACQ35567056-0CA42469-B378-456F-9FAD-7D1B5B5840EFQ35594220-72C6471F-B61C-4885-A9D6-39D2515CEAE7Q35745247-D5CBC817-4731-4B66-A209-1F7A19A98662Q35804451-B91BD21E-5A45-4A30-B8CD-C3BBEAB244AFQ36369790-26A86E38-3AC7-4BFE-A5DF-984024D9570BQ36370873-B58A83D1-A605-4314-BFFC-5E8315CA35EFQ36371167-D40341AC-29AE-487C-87BF-98BB8AD822D8Q36371187-C6426296-10B0-4754-AF08-C05E9BB84A1BQ36371212-439B3F1D-B983-4831-B35E-B85CDC4EE538Q36371218-95197F64-57E0-4F16-B6F4-A347A421DED8Q36376340-0F0A0103-F2E6-4396-A0E4-96F096CB05A1Q36376611-0FB695DE-B7EF-4D57-BA5A-0A00ED0D5706Q36978927-02AD21AC-B567-4543-A5D3-0CD73BEEB72AQ37070256-CC0FDDBE-7415-43CE-B7BF-C61333CFB2ACQ37088207-2035DB47-60D4-462C-AD70-0940300F6B32Q37114367-EDA5C7DB-AD08-4232-9D3D-862E1052EF67Q37129429-D5F0A509-5655-4F08-BB4D-9FAAC4AA481AQ37139265-0021FFBC-3CB0-4A5D-A2CE-F4406EFF5843Q37406555-3B098E81-3C66-4891-919E-2E033E472D9DQ37700814-25E9537F-ECFF-4BB4-913C-D724218D3E98Q37700824-42C229C7-002C-4C42-8CE5-9A0B23D8A50FQ37708023-3C97DA24-84A0-4910-86CE-03907BB6B2CB
P2860
Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo.
@ast
Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo.
@en
type
label
Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo.
@ast
Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo.
@en
prefLabel
Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo.
@ast
Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo.
@en
P2093
P1476
Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo.
@en
P2093
P304
P356
10.4049/JIMMUNOL.166.3.1439
P407
P577
2001-02-01T00:00:00Z